In these patients, “over a quarter to half of the risk of new infection was attributable to the alternative antibiotics,” Dr. Kimberly Blumenthal, study author and quality director of allergy and immunology at Massachusetts General Hospital, told MedPage Today.
Using a British cohort of adults the researchers located about 64,000 patients with a reported penicillin allergy to just over 237,000 people with no such allergy and then followed then did a six-year follow-up analysis.
Of those who had to rely on alternative antibiotics due to a previously diagnosed penicillin allergy, 1,345 patients developed MRSA and 1,688 developed C. difficile.
The patients hadn’t done testing to confirm their allergy to penicillin, meaning they may have been avoiding the antibiotic when they didn’t really need to.
What’s the Takeaway?
Past studies have found that over 90 of patients who report a penicillin allergy actually can tolerate this more effective and cheaper antibiotic. Allergists recommend retesting to see if you’ve outgrown the allergy.
Dr. David Lang, chairman of the department of allergy and immunology at the Cleveland Clinic says Blumenthal’s finding about infections adds an important reason for physicians to refer penicillin-allergic patients to an allergist. “Nine out of 10 – or even 19 of 20 – times we will be able to reduce the patient’s risk for bad outcomes by removing this label,” Lang told Allergic Living.
Blumenthal’s study was presented at the AAAAI/WAO joint meeting in Orlando in early March 2018.